Milestone Pharmaceuticals Secures First Overseas Etripamil Approval
Montreal, Quebec, and Charlotte, North Carolina — September 3, 2026 Milestone Pharmaceuticals announced that China’s National Medical Products Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Montreal, Quebec, and Charlotte, North Carolina — September 3, 2026 Milestone Pharmaceuticals announced that China’s National Medical Products Administration...
Fort Mill, S.C. – August 27, 2026 Catheter Precision, Inc. announced several commercial milestones for its LockeT® and VIVO™...
SOUTH SAN FRANCISCO, Calif., May 15, 2026 Tenaya Therapeutics reported encouraging interim Phase 1b/2 clinical data for TN-401, its...
MADRID, Spain, April 2026 Corify Care has achieved a major regulatory milestone with U.S. FDA 510(k) clearance for its...
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
